Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Synthesis and evaluation of stilbenylbenzoxazole and stilbenylbenzothiazole derivatives for detecting beta-amyloid fibrils

Full metadata record
DC Field Value Language
dc.contributor.authorLee, Ji Hoon-
dc.contributor.authorByeon, Seong Rim-
dc.contributor.authorLim, Soo Jeong-
dc.contributor.authorOh, Seung Jun-
dc.contributor.authorMoon, Dae Hyuk-
dc.contributor.authorYoo, Kyung Ho-
dc.contributor.authorChung, Bong Young-
dc.contributor.authorKim, Dong Jin-
dc.date.accessioned2021-09-09T11:11:23Z-
dc.date.available2021-09-09T11:11:23Z-
dc.date.created2021-06-10-
dc.date.issued2008-02-15-
dc.identifier.issn0960-894X-
dc.identifier.urihttps://scholar.korea.ac.kr/handle/2021.sw.korea/124080-
dc.description.abstractThis paper describes a novel series of stilbenylbenzoxazole ( SBO) and stilbenylbenzothiazole ( SBT) derivatives for beta- amyloid specific binding probes. These 24 compounds were synthesized and evaluated by competitive binding assay against beta- amyloid 1 - 42 ( A beta 42) aggregates using [I-125] TZDM. All the derivatives displayed higher binding affinities with K-i value in the subnanomolar range ( 0.10 - 0.74 nM) than Pittsburgh Compound- B ( PIB) ( 0.77 nM). Among these derivatives, SBT- 2, 5-. uoroethoxy- 2-{ 4-[ 2-( 4- methylaminophenyl) vinyl] phenyl} benzothiazole, showed lowest K-i value ( 0.10 nM). In conclusion, the preliminary results suggest that these compounds are implying a possibility as a probe for detection of A beta fibrils in Alzheimer's disease (AD) patients. (C) 2007 Elsevier Ltd. All rights reserved.-
dc.languageEnglish-
dc.language.isoen-
dc.publisherPERGAMON-ELSEVIER SCIENCE LTD-
dc.subjectALZHEIMERS-DISEASE-
dc.subjectIMAGING AGENTS-
dc.subjectMEDICINE-
dc.subjectPLAQUES-
dc.subjectPROBES-
dc.titleSynthesis and evaluation of stilbenylbenzoxazole and stilbenylbenzothiazole derivatives for detecting beta-amyloid fibrils-
dc.typeArticle-
dc.contributor.affiliatedAuthorChung, Bong Young-
dc.identifier.doi10.1016/j.bmcl.2007.10.004-
dc.identifier.scopusid2-s2.0-39049114657-
dc.identifier.wosid000254180000056-
dc.identifier.bibliographicCitationBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, v.18, no.4, pp.1534 - 1537-
dc.relation.isPartOfBIOORGANIC & MEDICINAL CHEMISTRY LETTERS-
dc.citation.titleBIOORGANIC & MEDICINAL CHEMISTRY LETTERS-
dc.citation.volume18-
dc.citation.number4-
dc.citation.startPage1534-
dc.citation.endPage1537-
dc.type.rimsART-
dc.type.docTypeArticle-
dc.description.journalClass1-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalResearchAreaPharmacology & Pharmacy-
dc.relation.journalResearchAreaChemistry-
dc.relation.journalWebOfScienceCategoryChemistry, Medicinal-
dc.relation.journalWebOfScienceCategoryChemistry, Organic-
dc.subject.keywordPlusALZHEIMERS-DISEASE-
dc.subject.keywordPlusIMAGING AGENTS-
dc.subject.keywordPlusMEDICINE-
dc.subject.keywordPlusPLAQUES-
dc.subject.keywordPlusPROBES-
dc.subject.keywordAuthorAlzheimer&apos-
dc.subject.keywordAuthors disease-
dc.subject.keywordAuthorbeta-amyloid fibrils-
dc.subject.keywordAuthorPET imaging-
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Science > Department of Chemistry > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE